Related references
Note: Only part of the references are listed.SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value
Mrinal M. Patnaik et al.
BLOOD (2012)
Mutations affecting mRNAsplicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes
Frederik Damm et al.
BLOOD (2012)
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes
Felicitas Thol et al.
BLOOD (2012)
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
Hideki Makishima et al.
BLOOD (2012)
Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML
Shinsuke Hirabayashi et al.
BLOOD (2012)
Myeloid malignancies: mutations, models and management
Anne Murati et al.
BMC CANCER (2012)
Long-term haematological improvement after non-intensive or no chemotherapy in juvenile myelomonocytic leukaemia and poor correlation with adult myelodysplasia spliceosome-related mutations
Kazuyuki Matsuda et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Splicing in oncogenesis and tumor suppression
Daisuke Kaida et al.
CANCER SCIENCE (2012)
Widespread recognition of 5′ splice sites by noncanonical base-pairing to U1 snRNA involving bulged nucleotides
Xavier Roca et al.
GENES & DEVELOPMENT (2012)
The zebrafish sf3b1b460 mutant reveals differential requirements for the sf3b1 pre-mRNA processing gene during neural crest development
Min An et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2012)
A Quantitative High-Throughput In Vitro Splicing Assay Identifies Inhibitors of Spliceosome Catalysis
Michael G. Berg et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients
T. L. Lasho et al.
LEUKEMIA (2012)
SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts
V. Visconte et al.
LEUKEMIA (2012)
Spliceosome and other novel mutations in chronic lymphocytic leukemia and myeloid malignancies
F. Damm et al.
LEUKEMIA (2012)
Clinical importance of SF3B1 mutations in Chinese with myelodysplastic syndromes with ring sideroblasts
Rui Cui et al.
LEUKEMIA RESEARCH (2012)
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
Timothy A. Graubert et al.
NATURE GENETICS (2012)
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
Victor Quesada et al.
NATURE GENETICS (2012)
Spliceosome mutations in hematopoietic malignancies
Christopher N. Hahn et al.
NATURE GENETICS (2012)
Chronic Lymphocytic Leukemia with SF3B1 Mutation
Victor Quesada et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Enantioselective Total Synthesis of Pladienolide B: A Potent Spliceosome Inhibitor
Arun K. Ghosh et al.
ORGANIC LETTERS (2012)
The cardiotonic steroid digitoxin regulates alternative splicing through depletion of the splicing factors SRSF3 and TRA2B
Erik S. Anderson et al.
RNA (2012)
Alternative splicing interference by xenobiotics
Emanuela Zaharieva et al.
TOXICOLOGY (2012)
Sudemycins, Novel Small Molecule Analogues of FR901464, Induce Alternative Gene Splicing
Liying Fan et al.
ACS CHEMICAL BIOLOGY (2011)
Identification of SAP155 as the Target of GEX1A (Herboxidiene), an Antitumor Natural Product
Makoto Hasegawa et al.
ACS CHEMICAL BIOLOGY (2011)
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
Luca Malcovati et al.
BLOOD (2011)
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness
Davide Rossi et al.
BLOOD (2011)
The Spliceosome as an Indicted Conspirator in Myeloid Malignancies
Omar Abdel-Wahab et al.
CANCER CELL (2011)
Amiloride Modulates Alternative Splicing in Leukemic Cells and Resensitizes Bcr-AblT315I Mutant Cells to Imatinib
Wen-Hsin Chang et al.
CANCER RESEARCH (2011)
Epigenetics in Alternative Pre-mRNA Splicing
Reini F. Luco et al.
CELL (2011)
Structural Requirements for the Antiproliferative Activity of Pre-mRNA Splicing Inhibitor FR901464
Sami Osman et al.
CHEMISTRY-A EUROPEAN JOURNAL (2011)
Biological validation that SF3b is a target of the antitumor macrolide pladienolide
Akira Yokoi et al.
FEBS JOURNAL (2011)
Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A
Anna Corrionero et al.
GENES & DEVELOPMENT (2011)
The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region
Eric G. Folco et al.
GENES & DEVELOPMENT (2011)
Synthesis and Characterization of Pseudocantharidins, Novel Phosphatase Modulators That Promote the Inclusion of Exon 7 into the SMN (Survival of Motoneuron) pre-mRNA
Zhaiyi Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Real-time imaging of cotranscriptional splicing reveals a kinetic model that reduces noise: implications for alternative splicing regulation
Ute Schmidt et al.
JOURNAL OF CELL BIOLOGY (2011)
Mechanisms and Consequences of Alternative Polyadenylation
Dafne Campigli Di Giammartino et al.
MOLECULAR CELL (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
Yimin Hua et al.
NATURE (2011)
Functional consequences of developmentally regulated alternative splicing
Auinash Kalsotra et al.
NATURE REVIEWS GENETICS (2011)
Spliceosome assembly is coupled to RNA polymerase II dynamics at the 3′ end of human genes
Sandra Bento Martins et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E. Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Lili Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Small Molecule Amiloride Modulates Oncogenic RNA Alternative Splicing to Devitalize Human Cancer Cells
Jan-Gowth Chang et al.
PLOS ONE (2011)
Proofreading and spellchecking: A two-tier strategy for pre-mRNA splicing quality control
Defne E. Egecioglu et al.
RNA (2011)
Association of TALS Developmental Disorder with Defect in Minor Splicing Component U4atac snRNA
Patrick Edery et al.
SCIENCE (2011)
Mutations in U4atac snRNA, a Component of the Minor Spliceosome, in the Developmental Disorder MOPD I
Huiling He et al.
SCIENCE (2011)
DEGRADE, MOVE, REGROUP: signaling control of splicing proteins
Florian Heyd et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Understanding splicing regulation through RNA splicing maps
Joshua T. Witten et al.
TRENDS IN GENETICS (2011)
Spliceosome Structure and Function
Cindy L. Will et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Chemical treatment enhances skipping of a mutated exon in the dystrophin gene
Atsushi Nishida et al.
NATURE COMMUNICATIONS (2011)
The In Vivo Kinetics of RNA Polymerase II Elongation during Co-Transcriptional Splicing
Yehuda Brody et al.
PLOS BIOLOGY (2011)
Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF
Ryohei Furumai et al.
CANCER SCIENCE (2010)
Heterogeneity in mammalian RNA 3 ' end formation
Joel R. Neilson et al.
EXPERIMENTAL CELL RESEARCH (2010)
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Yimin Hua et al.
GENES & DEVELOPMENT (2010)
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
Charles J. David et al.
GENES & DEVELOPMENT (2010)
Rapid-Response Splicing Reporter Screens Identify Differential Regulators of Constitutive and Alternative Splicing
Ihab Younis et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Invariant U2 snRNA Nucleotides Form a Stem Loop to Recognize the Intron Early in Splicing
Rhonda Perriman et al.
MOLECULAR CELL (2010)
A comprehensive catalogue of somatic mutations from a human cancer genome
Erin D. Pleasance et al.
NATURE (2010)
Expansion of the eukaryotic proteome by alternative splicing
Timothy W. Nilsen et al.
NATURE (2010)
Spliceostatin A inhibits spliceosome assembly subsequent to prespliceosome formation
Gabriel A. Roybal et al.
NUCLEIC ACIDS RESEARCH (2010)
Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: Therapeutic potential of bifunctional oligonucleotides and indole derivatives
Claudia Ghigna et al.
RNA BIOLOGY (2010)
Release of SF3 from the intron branchpoint activates the first step of pre-mRNA splicing
Rea M. Lardelli et al.
RNA (2010)
Pre-mRNA Processing Reaches Back to Transcription and Ahead to Translation
Melissa J. Moore et al.
CELL (2009)
The Spliceosome: Design Principles of a Dynamic RNP Machine
Markus C. Wahl et al.
CELL (2009)
MDM2 and MDM4 splicing: an integral part of the cancer spliceome
Selvi C. Jeyaraj et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Synthetic mRNA Splicing Modulator Compounds with in Vivo Antitumor Activity
Chandraiah Lagisetti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Alternative Splicing in Lung Cancer
Ruben Pio et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Meayamycin inhibits pre-messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells
Brian J. Albert et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Insights into Branch Nucleophile Positioning and Activation from an Orthogonal Pre-mRNA Splicing System in Yeast
Duncan J. Smith et al.
MOLECULAR CELL (2009)
Reconstitution of both steps of Saccharomyces cerevisiae splicing with purified spliceosomal components
Zbigniew Warkocki et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
The Biflavonoid Isoginkgetin Is a General Inhibitor of Pre-mRNA Splicing
Kristine O'Brien et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Antitumor compounds based on a natural product consensus pharmacophore
Chandraiah Lagisetti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes
Lulzim Shkreta et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R. Christofk et al.
NATURE (2008)
A high-throughout screening strategy identifies cardiotonic steroids as alternative splicing modulators
Peter Stoilov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Splicing regulation: From a parts list of regulatory elements to an integrated splicing code
Zefeng Wang et al.
RNA (2008)
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Steven J. Harper et al.
NATURE REVIEWS CANCER (2008)
The genomic landscapes of human breast and colorectal cancers
Laura D. Wood et al.
SCIENCE (2007)
U2 snRNP binds intronless histone pre-mRNAs to facilitate U7-snRN-dependent 3′ end formation
Kyle Friend et al.
MOLECULAR CELL (2007)
Splicing factor SF3b as a target of the antitumor natural product pladienolide
Yoshihiko Kotake et al.
NATURE CHEMICAL BIOLOGY (2007)
Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA
Daisuke Kaida et al.
NATURE CHEMICAL BIOLOGY (2007)
Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase/Akt-dependent matrix metalloproteinase-9 expression
Sang-Oh Yoon et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins
Yongna Xing et al.
CELL (2006)
SAP155 binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5′ splice site selection of Bcl-x pre-mRNA
Autumn Massiello et al.
FASEB JOURNAL (2006)
Utilization of host SR protein kinases and RNA-splicing machinery during viral replication
Takeshi Fukuhara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Direct interactions between subunits of CPSF and the U2 snRNP contribute to the coupling of pre-mRNA 3′ end processing and splicing
Andrea Kyburz et al.
MOLECULAR CELL (2006)
Alternative splicing: New insights from global analyses
Benjamin J. Blencowe
CELL (2006)
Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors
J Soret et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Major conformational change in the complex SF3b upon integration into the spliceosomal U11/U12 di-snRNP as revealed by electron cryomicroscopy
MM Golas et al.
MOLECULAR CELL (2005)
Mammalian polycomb-mediated repression of Hox genes requires the essential spliceosomal protein Sf3b1
K Isono et al.
GENES & DEVELOPMENT (2005)
Pladienolides, new substances from culture of Streptomyces platensis Mer-11107 I.: Taxonomy, fermentation, isolation and screening
T Sakai et al.
JOURNAL OF ANTIBIOTICS (2004)
Pladienolides, new substances from culture of Streptomyces platensis Mer-11107 II.: Physico-chemical properties and structure elucidation
T Sakai et al.
JOURNAL OF ANTIBIOTICS (2004)
Pladienolides, new substances from culture of Streptomyces platensis Mer-11107 III.: In vitro and In vivo antitumor activities
Y Mizui et al.
JOURNAL OF ANTIBIOTICS (2004)
Manipulation of alternative splicing by a newly developed inhibitor of Clks
M Muraki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Molecular architecture of the multiprotein splicing factor SF3b
MM Golas et al.
SCIENCE (2003)
GEX1 compounds, novel antitumor antibiotics related to herboxidiene, produced by Streptomyces sp -: 1.: Taxonomy, production, isolation, physicochemical properties and biological activities
Y Sakai et al.
JOURNAL OF ANTIBIOTICS (2002)
GEX1 compounds, novel antitumor antibiotics related to herboxidiene, produced by Streptomyces sp -: II.: The effects on cell cycle progression and gene expression
Y Sakai et al.
JOURNAL OF ANTIBIOTICS (2002)
Probing interactions between the U2 small nuclear ribonucleoprotein and the DEAD-box protein, Prp5.
BK Abu Dayyeh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA
ML Zhang et al.
GENE THERAPY (2001)
Share Paper
